The following parameters will be assessed in order to evaluate the Avastin effect: visual acuity, lesions's area at the ocular fundus one year [clinicaltrials_resource:b9a808c4f791cc11b2223a3631dfa81e]
2,5 mg Avastin intravitreal injections every 4 weeks, 6 months consecutively
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
The following parameters will be assessed in order to evaluate the Avastin effect: visual acuity, lesions's area at the ocular fundus one year [clinicaltrials_resource:b9a808c4f791cc11b2223a3631dfa81e]
2,5 mg Avastin intravitreal injections every 4 weeks, 6 months consecutively
Bio2RDF identifier
b9a808c4f791cc11b2223a3631dfa81e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b9a808c4f791cc11b2223a3631dfa81e
measure [clinicaltrials_vocabulary:measure]
The following parameters will ...... ns's area at the ocular fundus
time frame [clinicaltrials_vocabulary:time-frame]
description
2,5 mg Avastin intravitreal injections every 4 weeks, 6 months consecutively
identifier
clinicaltrials_resource:b9a808c4f791cc11b2223a3631dfa81e
title
The following parameters will ...... at the ocular fundus one year
@en
type
label
The following parameters will ...... 808c4f791cc11b2223a3631dfa81e]
@en